Literature DB >> 9420806

Mechanism of uptake of technetium-tetrofosmin. I: Uptake into isolated adult rat ventricular myocytes and subcellular localization.

E A Platts1, T L North, R D Pickett, J D Kelly.   

Abstract

BACKGROUND: 99mTc-labeled tetrofosmin is a new myocardial imaging agent that gives stable heart uptake. However, little is known about the mechanism of uptake in heart tissue. METHODS AND
RESULTS: Uptake of 99mTc-labeled tetrofosmin has been examined in isolated adult rat ventricular myocytes. The time course of uptake, efflux rate, and the effect of metabolic and cation channel inhibitors have been assessed. The subcellular localization of radioactivity in ex vivo rat heart tissue was examined by differential centrifugation of ventricular homogenate. Uptake into rat myocytes was found to be rapid and plateaued at approximately 1.5 pmol/10(6) cells/nmol extracellular Tc-labeled tetrofosmin after 60 minutes of incubation. Uptake was temperature dependent but independent of extracellular Tc-labeled tetrofosmin concentration. Uptake at 30 minutes was inhibited by the metabolic inhibitors iodoacetic acid acid and 2,4-dinitrophenol protein but was not affected by cation channel inhibitors. Cells previously incubated with 99mTc-labeled tetrofosmin and then placed into fresh medium were found to have a slow efflux of activity; after 1 hour, 65% of activity was still cell associated. The localization of radioactivity in subcellular fractions indicated that the majority of activity was recovered with the cytosol. However, examination of the distribution of two mitochondrial enzymes indicated that this may have been artifactual. Use of carbonyl cyanide m-chlorophenyl-hydrazone or oligomycin to perturb mitochondrial membrane potential decreased or increased recovery in the mitochondrial fraction, respectively.
CONCLUSIONS: 99mTc-labeled tetrofosmin uptake by myocytes is by a metabolism-dependent process that does not involve cation channel transport. The most likely mechanism for this is by potential driven diffusion of the lipophilic cation across the sarcolemmal and mitochondrial membranes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9420806     DOI: 10.1016/s1071-3581(05)80076-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  19 in total

1.  THE ISOLATION AND PROPERTIES OF CARDIAC RIBOSOMES AND POLYSOMES.

Authors:  D C EARL; A KORNER
Journal:  Biochem J       Date:  1965-03       Impact factor: 3.857

2.  Comparative myocardial uptake characteristics of hexakis (alkylisonitrile) technetium(I) complexes. Effect of lipophilicity.

Authors:  D Piwnica-Worms; J F Kronauge; B L Holman; A Davison; A G Jones
Journal:  Invest Radiol       Date:  1989-01       Impact factor: 6.016

Review 3.  Characterization of in vivo chemistry of cations in the heart.

Authors:  S A Mousa; S J Williams; H Sands
Journal:  J Nucl Med       Date:  1987-08       Impact factor: 10.057

4.  Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts.

Authors:  P A Carvalho; M L Chiu; J F Kronauge; M Kawamura; A G Jones; B L Holman; D Piwnica-Worms
Journal:  J Nucl Med       Date:  1992-08       Impact factor: 10.057

5.  Comparison of the transport of 42K+, 22Na+, 201Tl+, and [99mTc(dmpe)2 X Cl2]+ using human erythrocytes.

Authors:  H Sands; M L Delano; L L Camin; B M Gallagher
Journal:  Biochim Biophys Acta       Date:  1985-02-14

6.  Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol.

Authors:  D Jain; F J Wackers; J Mattera; M McMahon; A J Sinusas; B L Zaret
Journal:  J Nucl Med       Date:  1993-08       Impact factor: 10.057

7.  Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease.

Authors:  B S Sridhara; S Braat; P Rigo; R Itti; P Cload; A Lahiri
Journal:  Am J Cardiol       Date:  1993-11-01       Impact factor: 2.778

8.  Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia.

Authors:  A J Sinusas; Q Shi; M T Saltzberg; P Vitols; D Jain; F J Wackers; B L Zaret
Journal:  J Nucl Med       Date:  1994-04       Impact factor: 10.057

9.  Enhancement by tetraphenylborate of technetium-99m-MIBI uptake kinetics and accumulation in cultured chick myocardial cells.

Authors:  D Piwnica-Worms; J F Kronauge; M L Chiu
Journal:  J Nucl Med       Date:  1991-10       Impact factor: 10.057

10.  Effect of metabolic inhibition on technetium-99m-MIBI kinetics in cultured chick myocardial cells.

Authors:  D Piwnica-Worms; J F Kronauge; L Delmon; B L Holman; J D Marsh; A G Jones
Journal:  J Nucl Med       Date:  1990-04       Impact factor: 10.057

View more
  22 in total

Review 1.  Myocardial perfusion imaging agents: SPECT and PET.

Authors:  George A Beller; Steven R Bergmann
Journal:  J Nucl Cardiol       Date:  2004 Jan-Feb       Impact factor: 5.952

2.  Effectiveness of (99m)Tc-tetrofosmin for assessment of heart functions in micropigs.

Authors:  Min Young Lee; Sang Hun Lee; Jae Hong Park; Jung Sun Heo; Yu Jin Lee; Han Na Suh; Jung Jun Min; Young Soon Seo; Ho Jae Han
Journal:  J Vet Sci       Date:  2007-09       Impact factor: 1.672

3.  The use of PET scan in glioblastoma multiforme.

Authors:  George A Alexiou; Spyridon Tsiouris; Athanasios P Kyritsis; Konstantinos S Polyzoidis; Andreas D Fotopoulos
Journal:  J Neurooncol       Date:  2007-07-17       Impact factor: 4.130

Review 4.  A brief overview of metal complexes as nuclear imaging agents.

Authors:  Douglas S MacPherson; Kimberly Fung; Brendon E Cook; Lynn C Francesconi; Brian M Zeglis
Journal:  Dalton Trans       Date:  2019-10-07       Impact factor: 4.390

5.  Added value of attenuation-corrected Tc-99m tetrofosmin SPECT for the detection of myocardial viability: comparison with FDG SPECT.

Authors:  Riemer H J A Slart; Jeroen J Bax; Wim J Sluiter; Dirk J van Veldhuisen; Pieter L Jager
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

6.  Mitochondrial avid radioprobes. Preparation and evaluation of 7'(Z)-[125I]iodorotenone and 7'(Z)-[125I]iodorotenol.

Authors:  Henry F VanBrocklin; Stephen M Hanrahan; Joel D Enas; Erathodiyil Nandanan; James P O'Neil
Journal:  Nucl Med Biol       Date:  2006-11-28       Impact factor: 2.408

7.  (99m)Tc-Tetrofosmin brain SPECT in the assessment of meningiomas-correlation with histological grade and proliferation index.

Authors:  Andreas D Fotopoulos; George A Alexiou; Ann Goussia; Athanasios Papadopoulos; Athanasios P Kyritsis; Konstantinos S Polyzoidis; Spyridon Voulgaris; Spyridon Tsiouris
Journal:  J Neurooncol       Date:  2008-05-06       Impact factor: 4.130

8.  Myocardial imaging with 99mTc-Tetrofosmin: Influence of post-stress acquisition time, regional radiotracer uptake, and wall motion abnormalities on the clinical result.

Authors:  Assuero Giorgetti; Annette Kusch; Mirta Casagranda; Irene D'Aragona Tagliavia; Paolo Marzullo
Journal:  J Nucl Cardiol       Date:  2009-12-15       Impact factor: 5.952

9.  Evaluation of (64)Cu(DO3A-xy-TPEP) as a potential PET radiotracer for monitoring tumor multidrug resistance.

Authors:  Shuang Liu; Young-Seung Kim; Shizhen Zhai; Jiyun Shi; Guihua Hou
Journal:  Bioconjug Chem       Date:  2009-04       Impact factor: 4.774

10.  Noninvasive assessment of coronary microvascular dysfunction using Tc-99m tetrofosmin SPECT in patients with acute myocardial infarction.

Authors:  Yoshiteru Abe; Makoto Kondo; Tomoyuki Kubota; Ryota Matsuoka; Makoto Araki; Kiyoshi Doyama; Hitoshi Tanio
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.